About Ares Serono
Ares Serono was established in 1997 in Geneva, Switzerland, as an RD-focused entity in the pharmaceutical sector. Operations center on the development and manufacturing of drugs targeting various therapeutic areas, including reproductive health and neurology. The companys activities are supported by its domain, serono.com, and are conducted primarily from its Swiss base to serve global markets in biotechnology and healthcare.
- Headquarter Geneve, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ares Serono
Detailed funding history for Ares Serono
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ares Serono
Ares Serono has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Merck is engaged in science and technology solutions globally.
|
Locked | Locked | Locked |
Investor details for Ares Serono
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ares Serono
Investment portfolio details for Ares Serono
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ares Serono
Detailed financials for Ares Serono
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ares Serono Comparisons
Peer comparison for Ares Serono
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ares Serono
Detailed competitors of Ares Serono
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ares Serono
Complete news archive for Ares Serono
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ares Serono
Ares Serono was founded in 1997.
Ares Serono is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Ares Serono was established in 1997 in Geneva, Switzerland, as an RD-focused entity in the pharmaceutical sector. Operations center on the development and manufacturing of drugs targeting various therapeutic areas, including reproductive health and neurology. The companys activities are supported by its domain, serono.com, and are conducted primarily from its Swiss base to serve global markets in biotechnology and healthcare.
Ares Serono has 1 investor. Key investors include Merck.